Erba Diagnostics Inc (ERB) 3.45 $ERB
Erba Diagnostics Expands U.S. Distribution Network
GlobeNewswire - Mon Jan 26, 7:10AM CST
Erba Diagnostics, Inc. (NYSE MKT:ERB), strengthened its U.S. distribution network by having entered into a new agreement with Government Scientific Source and having strengthened and expanded the scope of an agreement with an existing, nationally, prominent channel partner.
ERB: 3.45 (-0.09)
ERBA Diagnostics Attains CE Mark for HB Vario A1c Detection System and Reagents for Management of Diabetes
GlobeNewswire - Wed Jan 21, 7:00AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB), has attained CE Mark clearance for the HB Vario A1c detection system and associated reagents. Monitoring A1c values can help healthcare providers manage complications from diabetes in patients.
ERB: 3.45 (-0.09)
ERBA Diagnostics (ERB) Jumps: Stock Moves 5.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 7:30AM CST
ERBA Diagnostics, Inc. (ERB) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
INGN: 33.53 (+2.32), ERB: 3.45 (-0.09)
ERBA Diagnostics Webcast Alert: Moves Presentation at OneMedForum to January 13, 2015
GlobeNewswire - Mon Jan 12, 1:01PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) is moving originally scheduled presentation at the OneMedForum to Tues, January 13, 2015 at 4:40 pm PST (7:40 pm EST).
ERB: 3.45 (-0.09)
ERBA Diagnostics to Present at OneMedForum January 12, 2015
GlobeNewswire - Mon Jan 05, 2:26PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the OneMedForum investor conference on Monday, January 12, 2015 at 2:40 pm PST (5:40 pm EST).
ERB: 3.45 (-0.09)
Insider Trading Alert - CODI, ERB And FDEF Traded By Insiders
at The Street - Thu Dec 18, 10:39AM CST
Stocks with insider trader activity include CODI, ERB and FDEF
CODI: 16.61 (+0.03), FDEF: 31.98 (+0.21), ERB: 3.45 (-0.09)
ERBA Diagnostics to Present at the LD Micro Conference December 4, 2014
GlobeNewswire - Wed Nov 26, 1:04PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the LD Micro Investor Conference Thursday, December 4, 2014 at 7:30 am PST (10:30 am EST).
ERB: 3.45 (-0.09)
ERBA Diagnostics misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:02AM CST
ERB: 3.45 (-0.09)
ERBA Diagnostics Reports 3rd Quarter Financial Results
GlobeNewswire - Mon Nov 10, 6:10AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, today announced third quarter 2014 financial results.
ERB: 3.45 (-0.09)
ERBA to Feature New Urinalysis and Diabetes Monitoring Systems at MEDICA 2014
GlobeNewswire - Fri Nov 07, 9:14AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) will be featuring two new fully automated diagnostic testing instruments, the Hb-Vario diabetes monitoring system and the Laura XL urinalysis processer, at MEDICA 2014 in Dusseldorf Germany, November 12-15. ERBA Diagnostics will also showcase its comprehensive range of testing products, including the Elisa systems for autoimmune and infectious disease, chemistry analyzers, hematology analyzers, urine analyzers and coagulation systems.
ERB: 3.45 (-0.09)
Erba Diagnostics reports November 10
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 9:52AM CST
ERB: 3.45 (-0.09)
ERBA Diagnostics to Report Third Quarter Financial Results November 10th; Management Conference Call to Follow
GlobeNewswire - Wed Nov 05, 9:28AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) will report its third quarter 2014 financial results Monday, November 10, 2014 at approximately 7:30 a.m. Eastern Time. ERBA Chief Executive Officer Mohan Gopalkrishnan, will host a management conference call at 9:00 a.m. Eastern Time to discuss the financial results and business developments.
ERB: 3.45 (-0.09)
ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics
GlobeNewswire - Wed Oct 22, 8:43AM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) today announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for Hematology and Clinical Chemistry are now available to hospitals, references labs and physician clinics in Brazil. ERBA Diagnostics' product line includes a comprehensive suite of instruments, reagents and kits for immunology, clinical chemistry, hematology, diabetes and infectious disease testing. ERBA Diagnostics intends to introduce its full suite of products to hospitals, references labs and physician clinics in Brazil as the product registrations in Brazil are completed.
ERB: 3.45 (-0.09)
Erba Diagnostics (ERB) Downgraded From Buy to Hold
at The Street - Fri Oct 17, 8:05AM CDT
Erba Diagnostics (ERB) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
ERB: 3.45 (-0.09)
AngioDynamics (ANGO) Jumps: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:25AM CDT
AngioDynamics (ANGO) was a big mover last session, with shares rising nearly 6% on the day.
ATEC: 1.34 (unch), EW: 134.23 (+1.89), ANGO: 18.78 (+0.18), ERB: 3.45 (-0.09)
AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:00AM CDT
For fiscal 2015, AngioDynamics Inc. (ANGO) raised its adjusted per share guidance to a range of 65 to 71 cents from the prior expectation of 64 to 70 cents, on the back of stronger than anticipated first-quarter results.
BSX: 14.98 (+0.24), ANGO: 18.78 (+0.18), ERB: 3.45 (-0.09)
Luminex Trends Up, Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 8:10AM CDT
Shares of Luminex Corporation (LMNX) have been on the rise since it reported impressive 2014 second-quarter results on Jul 28.
ATEC: 1.34 (unch), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09)
Masimo Gets CE Mark Approval for 11th Rainbow Parameter - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 12:50PM CDT
Masimo Corporation's (MASI) Oxygen Reserve Index (ORI) is the first non-invasive and continuous parameter of its kind which provides an insight into patients' oxygen reserve when they are receiving supplemental oxygen.
GE: 25.15 (+0.26), MASI: 27.38 (-0.21), OPK: 13.80 (-0.28), ERB: 3.45 (-0.09)
Mazor Robotics Ltd. (MZOR) in Focus: Stock Soars 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:18AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company saw its shares rise by over 11% on the day.
OPK: 13.80 (-0.28), MZOR: 11.79 (+0.16), ERB: 3.45 (-0.09)
Luminex xTAG GPP for Gastroenteritis Gets FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 2:30PM CDT
Further, FDA has cleared Luminex's xTAG GPP for use with specimens in Cary-Blair medium ??? a common transport medium for collection and preservation of microbiological specimens.
ATEC: 1.34 (unch), EW: 134.23 (+1.89), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09)
Erba Diagnostics Expands U.S. Distribution Network
GlobeNewswire - Mon Jan 26, 7:10AM CST
Erba Diagnostics, Inc. (NYSE MKT:ERB), strengthened its U.S. distribution network by having entered into a new agreement with Government Scientific Source and having strengthened and expanded the scope of an agreement with an existing, nationally, prominent channel partner.
ERB: 3.45 (-0.09)
ERBA Diagnostics Attains CE Mark for HB Vario A1c Detection System and Reagents for Management of Diabetes
GlobeNewswire - Wed Jan 21, 7:00AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB), has attained CE Mark clearance for the HB Vario A1c detection system and associated reagents. Monitoring A1c values can help healthcare providers manage complications from diabetes in patients.
ERB: 3.45 (-0.09)
ERBA Diagnostics (ERB) Jumps: Stock Moves 5.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 7:30AM CST
ERBA Diagnostics, Inc. (ERB) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
INGN: 33.53 (+2.32), ERB: 3.45 (-0.09)
ERBA Diagnostics Webcast Alert: Moves Presentation at OneMedForum to January 13, 2015
GlobeNewswire - Mon Jan 12, 1:01PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) is moving originally scheduled presentation at the OneMedForum to Tues, January 13, 2015 at 4:40 pm PST (7:40 pm EST).
ERB: 3.45 (-0.09)
ERBA Diagnostics to Present at OneMedForum January 12, 2015
GlobeNewswire - Mon Jan 05, 2:26PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the OneMedForum investor conference on Monday, January 12, 2015 at 2:40 pm PST (5:40 pm EST).
ERB: 3.45 (-0.09)
Insider Trading Alert - CODI, ERB And FDEF Traded By Insiders
at The Street - Thu Dec 18, 10:39AM CST
Stocks with insider trader activity include CODI, ERB and FDEF
CODI: 16.61 (+0.03), FDEF: 31.98 (+0.21), ERB: 3.45 (-0.09)
ERBA Diagnostics to Present at the LD Micro Conference December 4, 2014
GlobeNewswire - Wed Nov 26, 1:04PM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the LD Micro Investor Conference Thursday, December 4, 2014 at 7:30 am PST (10:30 am EST).
ERB: 3.45 (-0.09)
ERBA Diagnostics misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:02AM CST
ERB: 3.45 (-0.09)
ERBA Diagnostics Reports 3rd Quarter Financial Results
GlobeNewswire - Mon Nov 10, 6:10AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, today announced third quarter 2014 financial results.
ERB: 3.45 (-0.09)
ERBA to Feature New Urinalysis and Diabetes Monitoring Systems at MEDICA 2014
GlobeNewswire - Fri Nov 07, 9:14AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) will be featuring two new fully automated diagnostic testing instruments, the Hb-Vario diabetes monitoring system and the Laura XL urinalysis processer, at MEDICA 2014 in Dusseldorf Germany, November 12-15. ERBA Diagnostics will also showcase its comprehensive range of testing products, including the Elisa systems for autoimmune and infectious disease, chemistry analyzers, hematology analyzers, urine analyzers and coagulation systems.
ERB: 3.45 (-0.09)
Erba Diagnostics reports November 10
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 9:52AM CST
ERB: 3.45 (-0.09)
ERBA Diagnostics to Report Third Quarter Financial Results November 10th; Management Conference Call to Follow
GlobeNewswire - Wed Nov 05, 9:28AM CST
ERBA Diagnostics, Inc. (NYSE MKT:ERB) will report its third quarter 2014 financial results Monday, November 10, 2014 at approximately 7:30 a.m. Eastern Time. ERBA Chief Executive Officer Mohan Gopalkrishnan, will host a management conference call at 9:00 a.m. Eastern Time to discuss the financial results and business developments.
ERB: 3.45 (-0.09)
ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics
GlobeNewswire - Wed Oct 22, 8:43AM CDT
ERBA Diagnostics, Inc. (NYSE MKT:ERB) today announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for Hematology and Clinical Chemistry are now available to hospitals, references labs and physician clinics in Brazil. ERBA Diagnostics' product line includes a comprehensive suite of instruments, reagents and kits for immunology, clinical chemistry, hematology, diabetes and infectious disease testing. ERBA Diagnostics intends to introduce its full suite of products to hospitals, references labs and physician clinics in Brazil as the product registrations in Brazil are completed.
ERB: 3.45 (-0.09)
Erba Diagnostics (ERB) Downgraded From Buy to Hold
at The Street - Fri Oct 17, 8:05AM CDT
Erba Diagnostics (ERB) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
ERB: 3.45 (-0.09)
AngioDynamics (ANGO) Jumps: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:25AM CDT
AngioDynamics (ANGO) was a big mover last session, with shares rising nearly 6% on the day.
ATEC: 1.34 (unch), EW: 134.23 (+1.89), ANGO: 18.78 (+0.18), ERB: 3.45 (-0.09)
AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:00AM CDT
For fiscal 2015, AngioDynamics Inc. (ANGO) raised its adjusted per share guidance to a range of 65 to 71 cents from the prior expectation of 64 to 70 cents, on the back of stronger than anticipated first-quarter results.
BSX: 14.98 (+0.24), ANGO: 18.78 (+0.18), ERB: 3.45 (-0.09)
Luminex Trends Up, Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 8:10AM CDT
Shares of Luminex Corporation (LMNX) have been on the rise since it reported impressive 2014 second-quarter results on Jul 28.
ATEC: 1.34 (unch), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09)
Masimo Gets CE Mark Approval for 11th Rainbow Parameter - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 12:50PM CDT
Masimo Corporation's (MASI) Oxygen Reserve Index (ORI) is the first non-invasive and continuous parameter of its kind which provides an insight into patients' oxygen reserve when they are receiving supplemental oxygen.
GE: 25.15 (+0.26), MASI: 27.38 (-0.21), OPK: 13.80 (-0.28), ERB: 3.45 (-0.09)
Mazor Robotics Ltd. (MZOR) in Focus: Stock Soars 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:18AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company saw its shares rise by over 11% on the day.
OPK: 13.80 (-0.28), MZOR: 11.79 (+0.16), ERB: 3.45 (-0.09)
Luminex xTAG GPP for Gastroenteritis Gets FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 2:30PM CDT
Further, FDA has cleared Luminex's xTAG GPP for use with specimens in Cary-Blair medium ??? a common transport medium for collection and preservation of microbiological specimens.
ATEC: 1.34 (unch), EW: 134.23 (+1.89), LMNX: 15.45 (+0.02), ERB: 3.45 (-0.09)
